The liver is the most common organ for metastasis of various malignancies, especially for uveal melanoma (UM), colorectal cancer (CRC) and pancreatic ductal adenocarcinoma (PDAC). Precision medicine to chronic diseases, especially for liver cancer and metastasis, requires non-invasive precision diagnostics. Non-invasive precision imaging capable of early detection, staging and molecular subtyping/stratification of patients, is a major breakthrough. Rapid development and approval of precision medicine also requires precision imaging to evaluate drug efficacy at animal and patient levels. There is a pressing unmet medical need to develop MRI contrast agents and imaging methodologies with desired sensitivity and specificity .
How to access this content:
For one year after publication, abstracts and videos are only open to registrants of this annual meeting. Registrants should use their existing login information. Non-registrant access can be purchased via the ISMRM E-Library.
After one year, current ISMRM & ISMRT members get free access to both the abstracts and videos. Non-members and non-registrants must purchase access via the ISMRM E-Library.
After two years, the meeting proceedings (abstracts) are opened to the public and require no login information. Videos remain behind password for access by members, registrants and E-Library customers.
Keywords